PUBLICATION

GABA regulates electrical activity and tumor initiation in melanoma

Authors
Tagore, M., Hergenreder, E., Perlee, S.C., Cruz, N.M., Menocal, L., Suresh, S., Chan, E., Baron, M., Melendez, S., Dave, A., Chatila, W.K., Nsengimana, J., Koche, R.P., Hollmann, T.J., Ideker, T., Studer, L., Schietinger, A., White, R.M.
ID
ZDB-PUB-230810-58
Date
2023
Source
Cancer discovery   13(10): 2270-2291 (Journal)
Registered Authors
White, Richard M.
Keywords
none
MeSH Terms
  • Animals
  • Cell Transformation, Neoplastic/genetics
  • Humans
  • Keratinocytes
  • Melanocytes/pathology
  • Melanoma*/drug therapy
  • Melanoma*/genetics
  • Melanoma*/pathology
  • Skin
  • Tumor Microenvironment
  • Zebrafish
  • gamma-Aminobutyric Acid
PubMed
37553760 Full text @ Cancer Discov
Abstract
Oncogenes can only initiate tumors in certain cellular contexts, which is referred to as oncogenic competence. In melanoma, whether cells in the microenvironment can endow such competence remains unclear. Using a combination of zebrafish transgenesis coupled with human tissues, we demonstrate that GABAergic signaling between keratinocytes and melanocytes promotes melanoma initiation by BRAFV600E. GABA is synthesized in melanoma cells, which then acts on GABA-A receptors on keratinocytes. Electron microscopy demonstrates specialized cell-cell junctions between keratinocytes and melanoma cells, and multi-electrode array analysis shows that GABA acts to inhibit electrical activity in melanoma/keratinocyte co-cultures. Genetic and pharmacologic perturbation of GABA synthesis abrogates melanoma initiation in vivo. These data suggest that GABAergic signaling across the skin microenvironment regulates the ability of oncogenes to initiate melanoma.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping